Esketamine, the active ingredient in Spravato, is a non-selective, non-competitive antagonist of the NMDA receptor, a known ...

The FDA approved Johnson & Johnson’s Spravato nasal spray as a stand-alone treatment for patients suffering from severe ...

Johnson & Johnson (NYSE:JNJ) reported a fourth-quarter adjusted EPS of $2.04, down 10.9% year over year, beating the ...

90 Day Fiancé: Before the 90 Days star Veah Netherton is updating fans on her health after revealing a mystery illness on the ...

OKCPS: Rogers Middle School students to learn from home Wednesday due to broken water line Julie McFadden has cared for over ...

Trump's administration has cleared the way for arrests in schools of people suspected of being without legal status. And, ...

Johnson & Johnson (NYSE:JNJ) reported its third-quarter 2024 earnings, surpassing analysts' expectations with an adjusted earnings per share (EPS) of $2.04, slightly above the forecasted $2.02. The ...